Long Non-Coding RNA Expression in Alpha-1 Antitrypsin Deficient Monocytes Pre- and Post-AAT Augmentation Therapy

• Published in: Non-coding RNA Vol. 9; no. 1; p. 6
• Main Authors: Smith, Stephen G J, Greene, Catherine M
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 10.01.2023; MDPI
• Subjects: Adjuvant therapy; augmentation therapy; Chromosomes; Chronic obstructive pulmonary disease; Communication; Datasets; deficiency; DNA microarrays; Gene expression; Genes; MicroRNA; MicroRNAs; miRNA; Monocytes; Neutrophils; Nitric oxide; Non-coding RNA; Peripheral blood; Ireland; deficiency; augmentation therapy
• ISSN: 2311-553X; 2311-553X
• DOI: 10.3390/ncrna9010006

Long non-coding RNAs (lncRNAs) regulate gene expression. Their expression in alpha-1 antitrypsin (AAT) deficiency has not been investigated. Treatment of AAT deficiency involves infusion of plasma-purified AAT and this augmentation therapy has previously been shown to alter microRNA expression in monocytes of AAT-deficient (ZZ) individuals. Here, we assess the effect of AAT augmentation therapy on the lncRNA expression profile in ZZ monocytes. Peripheral blood monocytes were isolated from ZZ individuals pre (Day 0)- and post (Day 2)-AAT augmentation therapy. Arraystar lncRNA microarray profiling was performed; a total of 17,761 lncRNAs were detectable across all samples. The array identified 7509 lncRNAs with differential expression post-augmentation therapy, 3084 were increased and 4425 were decreased (fold change ≥ 2). Expression of many of these lncRNAs were similarly altered in ZZ monocytes treated ex vivo with 27.5 μM AAT for 4 h. These properties may contribute to the manifold effects of AAT augmentation therapy.